Philip C Hanna

Title: The Innovations of Philip C. Hanna

Introduction

Philip C. Hanna is an accomplished inventor based in Charlestown, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods to combat foodborne illnesses. His work focuses on Clostridium perfringens type A enterotoxin and its implications for public health.

Latest Patents

Hanna holds a patent for a method involving Clostridium perfringens type A enterotoxin toxoid and recombinant Escherichia coli strains. This patent describes the creation of plasmids that produce these toxoids, which are designed to bind to receptor sites on intestinal membranes. By saturating these sites, the toxoids effectively compete with the harmful Clostridium perfringens type A enterotoxin, potentially treating symptoms of food poisoning. Additionally, the patent outlines processes for preparing these plasmids and toxoids, as well as vaccines aimed at preventing Clostridium perfringens food poisoning.

Career Highlights

Hanna is affiliated with the University of Pittsburgh, where he continues to advance research in this critical area of health. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and treatment of foodborne pathogens.

Collaborations

Hanna has collaborated with notable colleagues such as Bruce A. McClane and Timothy A. Mietzner. Their joint efforts have furthered research and development in the field of microbiology and food safety.

Conclusion

Philip C. Hanna's work exemplifies the impact of innovation in addressing public health challenges. His contributions to the understanding of Clostridium perfringens type A enterotoxin and the development of effective treatments highlight the importance of research in biotechnology.